Vela Pharmaceuticals, Inc.

City:

Ewing, New Jersey

Country:

United States

Published Applications:

Last publication date:

2007-06-21

Patent Grants:

Last grant date:

2009-06-02

Top Inventors for applications by Vela Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Vela Pharmaceuticals, Inc.:

Robert F. Kucharik 6 Glenmoore, PA United States
Steven M. Leventer 3 Langhorne, PA United States
Jeff Calcagno 2 Hopewell, NJ United States
Naidong Ye 2 Malvern, PA United States

Kimm Galbraith 1 Spring City, PA United States
Jianfeng Shi 1 Baltimore, MD United States
Naidaong Ye 1 Malvern, PA United States
Scott R. Perrin 1 Boothwyn, PA United States

Mallikarjun Reddy Ravi 1 Baltimore, MD United States
Wilhelm Hauck 1 Wallingford, PA United States
Kimm B. Galbraith 1 Spring City, PA United States
Yungen Xu 1 Baltimore, MD United States

Kimm Galbraith 1 Spring City, MD United States
Wuyi Wang 1 Silver Spring, MD United States
Yong Victoria Wei 1 Branchburg, NJ United States
Herbert W. Harris 1 Merion, PA United States

Steve Leventer 1 Langhorne, PA United States
Brian T. Speicher 1 Lansdale, PA United States

Recent patent applications by Vela Pharmaceuticals, Inc.

Vela Pharmaceuticals, Inc. based in Ewing, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2007-06-21

US20070142396A1

Human necessities

Treatment of pain with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof

#2 | 2007-06-21

US20070142395A1

Human necessities

Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof

#3 | 2007-01-25

US20070021412A1

Human necessities

Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepine

#4 | 2006-11-23 ✅ Patent 7,541,355 granted on 2009-06-02

US20060264421A1

Chemistry; metallurgy

Conversion process for 2,3-benzodiazepine enantiomers

#5 | 2006-07-27

US20060166976A1

Human necessities

Compositions and methods for treating or preventing convulsions or seizures

#6 | 2006-06-15

US20060128955A1

Chemistry; metallurgy

Method of isolating (R)-tofisopam

#7 | 2006-04-04 ✅ Patent 7,022,700 granted on 2006-04-04

US10309527

Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines

#8 | 2005-10-13

US20050227961A1

Human necessities

Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome

AssigneeID:

276484 ⎘